ABOUT US
Empowering GSAS students for success, the Harvard Griffin GSAS Consulting Club (HGCC) offers an expansive platform to delve into the world of consulting. With a vibrant community of 1,000+ members, HGCC brings you consulting insights through networking events, specialized panels, and our annual Consulting Career Fair.
Engage in hands-on experience with the Harvard/MIT Case Competition and Harvard Griffin GSAS Volunteer Consulting Group (HGVCG). Elevate your interview prowess with tailored workshops, including case preparation and behavioral interview strategies.
Join HGCC for a transformative journey into the realm of consulting.
Meet the Executive Board
Established in 2006, the HGCC is guided by an Executive Board composed of committed graduate students and postdoctoral fellows from various departments across Harvard University. The Presidents, along with Senior Vice Presidents and Vice Presidents from our teams, collaborate to organize and spearhead diverse programming initiatives for the HGCC community.
Presidents
%20-%20Taylor%20Covington_edited_j.jpg)
President
Taylor Covington
Taylor is a PhD Candidate in the Harvard Biological and Biomedical Sciences program and the Leder Human Biology & Translational Medicine Program. She is co-advised by Dr. Thomas Michel and Dr. Ed Chouchani. Her thesis work focuses on how perinatal oxidative stress impacts cardiac development.
President
Shelley Cheng
Shelley is a Ph.D. Candidate in Astronomy & Astrophysics at Harvard University. Her thesis work is advised by Prof. Charlie Conroy and focuses on modeling the eruptive mass loss observed to occur in massive stars. She will be joining McKinsey & Company's New Jersey office as an Associate in mid-2026.
Partnerships and Engagement
Senior VP of Partnerships and Engagement
Basit Salik
Basit is a cancer immunologist and postdoctoral fellow at Harvard Medical School/Brigham and Women’s Hospital. His research focuses on hematopoietic stem cell aging and the development of therapeutic strategies for cancers of the blood. He earned his Ph.D. in immuno-oncology and brings a perspective that bridges scientific research and strategic thinking.
Senior VP of Partnerships and Engagement
David Wood
David is a postdoctoral fellow researching the impact of metabolic signals on disease progression and cellular function. He received his PhD in biophysics and biochemistry in New Zealand focusing on new strategies to combat the growing issue of antimicrobial resistance.
Senior VP of Partnerships and Engagement
Ezra Jones
Ezra is a J.D. Candidate at Harvard Law School. His interests lie in corporate law, financial regulation and the intersection of law and business. Last summer, he interned at the U.S. Securities and Exchange Commission in Boston.
Senior VP of Partnerships and Engagement
Karla Martinez Nevarez
Karla is a PhD Candidate in the Harvard Biological and Biomedical Sciences program and the Program in Genetics and Genomics. Her thesis works focuses on the impact of environmental factors on gene expression and regulation programs in humans.
Senior VP of Partnerships and Engagement
Ross Hills
Ross is an MPH candidate at the Chan School of Public Health, focusing on health management. Coming from the UK, he is a qualified dentist and brings with him national policy experience.
VP of Professional Relations and Development
Alex Magnuson
Alex is a Ph.D. Candidate in Business Economics at Harvard University. His thesis work is advised by Prof. Marc Melitz and focuses on the the use of big data by firms to reduce uncertainty.
VP of Professional Relations and Development
Claire Hinrichs
Claire is a Ph.D. Candidate studying Physics & Astronomy. Her thesis work is advised by Prof. Wystan Benbow and focuses on modeling the high-energy outbursts that have been observed coming from black holes.
VP of Professional Relations and Development
Janys Li
Janys is a M.S. Candidate in Data Science at Harvard University. She has previously worked as a data science consultant at Ekimetrics, AI developer at Cathay Pacific, and cognitive science research assistant at ACME Lab at UCLA.
VP of Professional Relations and Development
Jordan Vanderpool
Jordan is a Ph.D. student in Romance Languages and Literatures at Harvard University. While his interests span a wide array of subjects and languages, he primarily studies economic debates in medieval Iberian literature.
VP of Community Engagement
Valay Patel
Valay is a Ph.D candidate in the Harvard Biological Sciences in Public Health program. He is a G1 and still rotating in different labs.
Case Competition
Senior VP of Case Competition
Amanda Smythers
Amanda is a postdoctoral fellow in the labs of Bruce Spiegelman and Steve Gygi. She received a PhD in Analytical Chemistry from UNC Chapel Hill, where she specialized in mass spectrometry-based proteomics.
Senior VP of Case Competition
Dwayne Evans
Dwayne is a PhD Candidate in the Harvard Biological and Biomedical Sciences program. His thesis work in the lab of Suzanne Walker focuses on the mechanisms and drug targets for cell wall and cell envelope synthesis in the Gram-positive bacterium, Staphylococcus aureus.
Senior VP of Case Competition
Jennifer Su
Jennifer is a PhD Candidate in the Harvard Biological and Biomedical Sciences program and the Leder Human Biology & Translational Medicine Program. She is completing her thesis work in the lab of Dr. Roby Bhattacharyya at Broad Institute. Her project focuses on understanding the community-level antibiotic resistance observed in Carbapenem-resistant Enterobacterales (CRE).
Senior VP of Case Competition
Noah Zhang
Noah is a PhD candidate in the Molecules, Cells, and Organisms (MCO) program at Harvard University. His thesis work is advised by Dr. Dragana Rogulja and focuses on elucidating how the brain's circadian clock adapts to environmental stress to regulate behavior and physiology in Drosophila.
Senior VP of Case Competition
Yishi Yang
Yishi is a first-year student in the Master in Public Administration in International Development (MPA/ID) program at the Harvard Kennedy School. Her academic and professional interests center on health policy and economic development, with a focus on improving healthcare access and outcomes through data-driven policy solutions.
VP of Case Competition
Adam Hernandez
Adam is a master’s candidate in Management at Harvard Extension School. The native Texan has a deep background in brand communications and marketing, with more than a decade of experience at companies like Southwest Airlines, Microsoft, and McDonald’s.
VP of Case Competition
Gaganpreet Kaur
Gaganpreet Kaur is a Postdoctoral Research Fellow in Vascular Biology at Harvard Medical School and Mass General Brigham. Funded by the American Heart Association, her research focuses on stress signaling in cardiovascular disease and employs glycoanalytical approaches to study the mechanobiology of endothelial cells.
VP of Case Competition
Jessica Liu
Jessica is a first year Ph.D. Candidate in Bioengineering at Harvard University.
VP of Case Competition
Liam Theveny
Liam is a Ph.D. Candidate in Biophysics at Harvard University. He uses advanced cryo-electron microscopy techniques to look at molecular machines directly within their native environments in the cell.
Volunteer Consulting Group (HGVCG)
Vice President & Principal of Volunteer Consulting Group
Ivan Susin Pires
Ivan is a Postdoctoral Fellow at Brigham and Women’s Hospital, where he is part of the Center for Engineered Therapeutics led by Dr. Shiladitya Sengupta. His research focuses on developing novel cancer therapies.
Vice President & Principal of Volunteer Consulting Group
Jennifer Jiang
Jennifer is a Ph.D. candidate in the Systems, Synthetic, and Quantitative Biology (SSQB) program at Harvard University. In Dr. Phil Cole’s lab, Jennifer's research focuses on engineering tools for understanding protein post-translational modifications involved in epigenetic regulation and cancer.
Vice President & Principal of Volunteer Consulting Group
Tim Dorweiler
Tim is a Fellow at Boston Children's Hospital and Harvard Medical School, supervised by Dr. Timothy Hla. His work revolves around the discovery of new treatments for diabetic microvascular diseases.